TNFRSF9 and neoplasm: The production of IL12a in dendritic cells was promoted by ILA by facilitating the increase in H3K27ac binding to IL12a enhancer regions, thereby aiding in the activation of CD8+ T cell (cytotoxic T lymphocyte, CTL) responses against tumor development [113].